Literature DB >> 9096926

Anabolic steroid use as the possible precipitant of dilated cardiomyopathy.

P C Ferrera1, D L Putnam, V P Verdile.   

Abstract

Anabolic-androgenic steroid (AAS) use is common among young males, including adolescents. There have been several anecdotal reports of severe cardiovascular events in self-reported young users of AAS, including acute myocardial infarction, sudden cardiac death, and cardiomyopathy. We present an additional case of a young male weight lifter who presented with dyspnea and chest pain attributable to dilated cardiomyopathy (DC), his only known risk factor being the recent use of AAS. The possible role of AAS in the development of DC is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096926     DOI: 10.1159/000177333

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  10 in total

1.  Effects of substitutive therapy on right ventricular systolic and diastolic functions in patients with idiopathic hypogonadotropic hypogonadism.

Authors:  Y T Yaylali; G Fidan Yaylali; F Akin; I Susam; M Bastemir
Journal:  J Endocrinol Invest       Date:  2010-09-02       Impact factor: 4.256

Review 2.  Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.

Authors:  Eberhard Nieschlag; Elena Vorona
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

3.  Building Body With Anabolics Is Weakening the Heart: Anabolic Steroid Induced Cardiomyopathy.

Authors:  Pradnya Brijmohan Bhattad; Mazen Roumia
Journal:  Cureus       Date:  2022-07-05

4.  Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patient.

Authors:  Reham Mohammed Shamloul; Ahmed Fathy Aborayah; Assem Hashad; Foad Abd-Allah
Journal:  BMJ Case Rep       Date:  2014-02-26

5.  Anabolic steroid-induced cardiomyopathy underlying acute liver failure in a young bodybuilder.

Authors:  Miguel Bispo; Ana Valente; Rosário Maldonado; Rui Palma; Helena Glória; João Nóbrega; Paula Alexandrino
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

6.  Performance-Enhancing Drugs Abuse Caused Cardiomyopathy and Acute Hepatic Injury in a Young Bodybuilder.

Authors:  Cheng Li; Binay Kumar Adhikari; Lu Gao; Shuai Zhang; Quan Liu; Yonggang Wang; Jian Sun
Journal:  Am J Mens Health       Date:  2018-06-21

7.  Non-ischemic Cardiomyopathy Secondary to Left Ventricular Hypertrophy due to Long-term Anabolic-androgenic Steroid Use in a Former Olympic Athlete.

Authors:  Edward T Ha; Michael L Weinrauch; Jeffrey Brensilver
Journal:  Cureus       Date:  2018-09-17

Review 8.  Anabolic-androgenic steroids and cardiovascular risk.

Authors:  Jian-Di Liu; Yan-Qing Wu
Journal:  Chin Med J (Engl)       Date:  2019-09-20       Impact factor: 2.628

9.  Sudden cardiac death in anabolic androgenic steroids abuse: case report and literature review.

Authors:  Ana Isabel Hernández-Guerra; Javier Tapia; Luis Manuel Menéndez-Quintanal; Joaquín S Lucena
Journal:  Forensic Sci Res       Date:  2019-08-19

10.  Correlation of neuter status and expression of heritable disorders.

Authors:  Janelle M Belanger; Thomas P Bellumori; Danika L Bannasch; Thomas R Famula; Anita M Oberbauer
Journal:  Canine Genet Epidemiol       Date:  2017-05-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.